We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nuformix Plc | LSE:NFX | London | Ordinary Share | GB00BYW79Y38 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -5.00% | 0.19 | 0.18 | 0.20 | - | 2,652,375 | 16:35:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -859k | -0.0012 | -1.67 | 1.49M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/4/2021 10:43 | From Oxilio website,Our approach to drug repurposing sets us apart from most other repurposing companies. We aim to repurpose an existing drug through optimisation of the formulation, dose and dosing regimen in order to maximise its efficacy in the new indication. Our OXL001 clinical trial programme is being designed to satisfy all aspects of drug safety and efficacy associated with optimal formulation, dose and dosing regimen of OXL001 in the treatment of cancer. The programme is informed by our advanced formulation and modelling/simulation work. We aim to take our first formulation of OXL001 into the clinic later in 2021. | georgeo1 | |
09/4/2021 08:55 | Fundraise coming lol! They only got the money from the recent one last week. | soupdragon55 | |
09/4/2021 00:29 | Holding RNS, it's a sell. Another fundraise coming i suppose | letmepass | |
08/4/2021 23:46 | It's got to be a sell managed over days | rodrod1 | |
08/4/2021 19:45 | Outstanding. I hope that's a buy!! | for fx sake | |
08/4/2021 19:20 | 18 million buy showing £468k over 3% | spurs90 | |
08/4/2021 15:47 | 2.61p to sell at present | maytrees | |
08/4/2021 15:43 | Some large trades and at least an offer share price gain so far. | maytrees | |
06/4/2021 16:53 | £5 million added to market cap today. | georgeo1 | |
30/3/2021 21:52 | https://www.uk-cpi.c | georgeo1 | |
30/3/2021 18:35 | Place of completion Wilton, UK Same location as in the nfx holdings rns. | georgeo1 | |
30/3/2021 18:31 | CPI .https://www.uk-cpi. | georgeo1 | |
30/3/2021 15:51 | https://twitter.com/ | georgeo1 | |
30/3/2021 13:19 | One failure. Good news for Nuformix &Oxilio. https://pulmonaryfib | georgeo1 | |
30/3/2021 08:39 | Any news on licensing could send the share price upwards it's a matter of time. Probably sorting out right now with Oxilio partnership. | georgeo1 | |
30/3/2021 08:26 | A million dumped straight off the mark. Hope that's not one of our newer investors. | for fx sake | |
29/3/2021 14:27 | https://pharmaphorum | georgeo1 | |
29/3/2021 10:55 | So ...there's undisclosed amount being received here. Might be more than the placing amount. | georgeo1 | |
29/3/2021 10:40 | The Placing is conditional upon approval by shareholders of the passing of certain resolutions to be proposed at a general meeting of the Company to be held on 29 March 2021 (the "General Meeting")...pursue additional business development opportunities for NXP001 in oncology should Oxilio not exercise the option to license NXP001 in oncology. Oxilio have already done this , does that mean it's still on. | georgeo1 | |
29/3/2021 09:20 | Latest news ...results from AGM all duly passed. Whoop whoop lol. | georgeo1 | |
26/3/2021 10:09 | There is a small chance of a boost this afternoon if they get their Innovate grant. | for fx sake | |
26/3/2021 09:25 | Am afraid it's back to 2p here, nice while it lasted , lots of shares to spread around now. | jotoha2 | |
25/3/2021 21:46 | See if NFX makes any gains on Friday towards Mondays agenda. Should be interesting to watch this space. | georgeo1 | |
25/3/2021 07:04 | See page 17 of the brokers note for a timeline of NXP002 | soupdragon55 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions